RBC Life Sciences Supports Clean Energy by Purchasing Renewable Energy Credits to...

RBC Life Sciences Supports Clean Energy by Purchasing Renewable Energy Credits
to Offset 100 Percent of Its Electricity Usage

IRVING, Texas, Jan. 12 /PRNewswire-FirstCall/ -- RBC Life Sciences (OTC
Bulletin Board: RBCL), a global provider of proprietary nutritional
supplements, wound care and pain management products, is offsetting 100
percent of its electricity usage for two years as part of a company-wide green
initiative.

RBC Life Sciences is purchasing 2,561,550 kilowatt hours of renewable energy
credits, which will help to avoid more than 3.4 million pounds of carbon
dioxide pollution. Over a two-year span, this commitment has an impact
comparable to planting more than 14,000 mature trees and avoiding the
pollution associated with driving 3.4 million miles in an average car.

RBC Life Sciences has also embarked on other energy-saving initiatives. The
company uses recycled paper as cushioning in product shipments, new printer
ink technology that will eliminate hundreds of pounds of used printer
cartridges and special lighting and printing technologies that drastically
reduce energy consumption.

"RBC Life Sciences' commitment to sustainable energy meshes well with the
company's focus on providing nutritional supplements and skin care products
that highlight natural ingredients," said company President and CEO John W.
Price. "This company-wide commitment to reduce our carbon footprint is part of
a larger company effort to promote clean energy projects and help America
become less dependent on fossil fuels."

RBC Life Sciences is purchasing the renewable energy credits from Renewable
Choice Energy, a Colorado-based company that works with the nation's
alternative energy sector. Every credit purchased helps fund new renewable
energy projects, such as wind farms.

About RBC Life SciencesRBC Life Sciences develops, manufactures and markets
high-quality nutritional supplements and personal care products to a growing
population of consumers seeking wellness and a healthy lifestyle. Under its
MPM Medical Inc. brand, RBC Life Sciences also develops and markets to health
care professionals in the United States proprietary prescription and
nonprescription products for advanced wound care and pain management. All
products are tested for quality assurance in-house, and by outside independent
laboratories, to comply with regulations in the U.S. and in more than thirty
countries in which the products are distributed. For more information, visit
the Company's Web site at www.rbclifesciences.com.

The statements above, other than statements of historical fact, may be
forward-looking. Actual events will be dependent upon a number of factors and
risks including, but not limited to, changes in plans by the Company's
management, delays or problems in production, changes in the regulatory
process, changes in market trends, and a number of other factors and risks
described from time to time in the Company's filings with the Securities and
Exchange Commission.

SOURCE RBC Life Sciences

Alan Van Zelfden, +1-972-893-4050, alan.vanzelfden@rbclifesciences.com, or Ann
Billings, +1-972-893-4000, ann.billings@rbclifesciences.com, both of RBC Life
Sciences